Dynamic Technology Lab Private LTD Madrigal Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

  • $601 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$231.06 - $307.08 $663,142 - $881,319
2,870 New
2,870 $695,000
Q3 2022

Nov 14, 2022
SELL
$60.57 - $79.51 $13,325 - $17,492
-220 Reduced 6.53%
3,150 $205,000
Q2 2022

Aug 12, 2022
BUY
$58.04 - $100.2 $195,594 - $337,674
3,370 New
3,370 $241,000
Q3 2021

Nov 15, 2021
SELL
$78.35 - $105.02 $174,720 - $234,194
-2,230 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$97.2 - $137.59 $216,756 - $306,825
2,230 New
2,230 $217,000

Others Institutions Holding MDGL

# of Institutions
335
Shares Held
22.2M
Call Options Held
960K
Put Options Held
940K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.92B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email